Guest Post February 14, 2012 Health antimicrobial agents , cdc , cephalosporins , chapel hill , communicable disease , drug resistant gonorrhea , ethnic group , fluoroquinolone resistant , fluoroquinolones , gail a bolan , gonococcal infections , gonorrhea , gonorrhea bacteria , judith n wasserheit , mics , minimum inhibitory concentrations , n gonorrhoeae , neisseria gonorrhoeae , oral cefixime , p frederick sparling , penicillins , race , resistant gonorrhea , seattle , sexual orientation , sulfanilamide , tetracyclines , third generation cephalosporins , threat , united states , university of north carolina , university of washington , untreatable gonococcal infection , urinary tract Researchers are continuing to sound the alarm on the growing threat of multi-drug resistant gonorrhea in the United States, according to a perspective in the Feb. 9 issue of the New England Journal of Medicine.
In July of 2011, the U.S. Centers for Disease Control and Prevention released “ Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates – United States, 2000-2010 ,” which signaled the potential for resistance to the cephalosporins, the last line of defense for treating gonorrhea. (more…)
Read More
